Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 465 results found. Search for [ Dr Reddy's Laboratories ]

Results 80 to 100 of 465
PB Jayakumar
New Delhi, April 1, 2020
Chemical and specialty chemical companies are revising their sourcing strategies


PB Jayakumar
March 22, 2020
The government has announced it will promote common infrastructure facilities in three 'Bulk Drug Parks' with the financial investment of Rs 3,000 crore in the next five years


BusinessToday.In
March 17, 2020
Stocks to watch today on March 18: Dr Reddy's, Delta Corp, Muthoot Finance among others are the top stocks to watch out for in Wednesday's trading session


Rupa Burman Roy
March 5, 2020
Barring shares of Piramal Enterprises that fell around 0.3%, all the 9 other healthcare shares were trading higher on Nifty Pharma, that was up 0.78% at 8,200.


BusinessToday.In
February 28, 2020
Stocks to watch today on March 2: RIL,Adani Gas, Maruti, HPCL, M&M, Dr Reddy's Labs, Motherson Sumi, Sudarshan Chemicals among others are the top stocks to watch out for in Monday's trading session


Satish Reddy
February 28, 2020
The Indian pharmaceutical industry has taken robust strides in ensuring the highest possible standards in quality and efficacy of medicines at affordable costs to patients


BusinessToday.In
New Delhi, February 16, 2020
As notified by the USFDA, the inspection classification of Dr Reddy's Duvvada facility has been determined as 'Voluntary Action Initiated'


PTI
February 16, 2020
Unichem is recalling 1.91 crore units of Clonidine Hydrochloride tablets and Macleods is recalling 4,694 bottles of Pioglitazone and Metformin Hydrochloride tablets used for treating high BP


E Kumar Sharma
February 13, 2020
The deal will enable adequate liquidity for robust growth in international operations and investments in Biosimilars for the US market; augment the remaining domestic branded business portfolio of the company and re-focus towards chronic segment with differentiated product portfolio, according to Wockhardt


BusinessToday.In
New Delhi, February 12, 2020
The deal comprises a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines


E Kumar Sharma
January 28, 2020
According to analysts, the company posted \"a good set of numbers, especially from the point of margin performance\" for the third quarter. As for the USFDA inspection, the current inspection gains importance given that it is last of the pending warning letters awaiting clearance


BusinessToday.In
New Delhi, January 27, 2020
Ace investor Rakesh Jhunjhunwala's portfolio component stock on Monday hit its all-time high after the water and environment management firm reported a 237% rise in Q3 net profit. Net profit rose to Rs 26.31 crore in the quarter ended December 2019 against net profit of Rs 7.93 crore in Q3 of previous fiscal. Jhunjhunwala held 8 lakh shares or 6.54% stake in the firm at the end of December quarter. He bought the stock for first time in December 2007 quarter and held 2.53% stake or 3,19,000 shares of the firm in the end of December quarter that year. Watch the video for more.Also Read: Dr Reddy's Laboratories share price hits 52-week high despite Rs 570-crore loss in Q3


BusinessToday.In
January 27, 2020
Stocks to watch today on January 28: Indigo, HDFC, Torrent Pharma, Dr Reddy, DCM Shriram, Wockhardt among others are the top stocks to watch out for in Tuesday's trading session


BusinessToday.In
January 27, 2020
Share price of Dr Reddy's Laboratories rose up to 5.92% to Rs 3,207.40 compared to the previous close of Rs 3,028.05 on BSE


BusinessToday.In
January 27, 2020
Share Market Update: IndiGo, United Spirits, HDFC, Torrent Pharma, TTK Prestige among others will be releasing their Q3 results today


BusinessToday.In
January 24, 2020
Stocks to watch today on January 27: Indian Bank, JSW Steel, UltraTech Cement, Sonata Software, Adani Gas, HDFC, Infosys, HDFC Bank, Wockhardt, Dr Reddy, Torrent Pharma, TTK Prestige among others are the top stocks to watch out for in Monday's trading session


E Kumar Sharma
New Delhi, January 1, 2020
Biosimilars are a different ball game -- more complex and more expensive, essentially because biotech drugs, by their very nature, require understanding of living organisms


BusinessToday.In
December 30, 2019
Stocks in the news: Dr Reddy's Laboratories, RIL, Airtel, Vodafone, UCO Bank, Balmer Lawrie, DHFL India, Andhra Bank among others are the top stocks to watch out for Tuesday's trading session


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


BusinessToday.In
November 20, 2019
Market witnessed bullishness in the initial trading session mainly on the back of favourable cues on the domestic front.


PAGES 5 OF 24  12345